Taysha Gene Therapies shares owned by Geode Capital Management
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 5.2M | 3.27 |
| 2025-06-30 | $8.8M | 3.8M | 2.31 |
| 2025-03-31 | $5.1M | 3.7M | 1.39 |
| 2024-12-31 | $6.2M | 3.6M | 1.73 |
| 2024-09-30 | $7.2M | 3.6M | 2.01 |
| 2024-06-30 | $6.5M | 2.9M | 2.24 |
| 2024-03-31 | $2.9M | 1.0M | 2.87 |
| 2023-09-30 | $1.5M | 462k | 3.16 |
| 2023-06-30 | $237k | 358k | 0.66 |
| 2023-03-31 | $300k | 377k | 0.80 |
| 2022-12-31 | $749k | 332k | 2.26 |
| 2022-09-30 | $464k | 240k | 1.93 |
| 2022-06-30 | $886k | 238k | 3.72 |
| 2022-03-31 | $2.7M | 410k | 6.52 |
| 2021-12-31 | $4.6M | 391k | 11.65 |
| 2021-09-30 | $6.8M | 363k | 18.62 |
| 2021-06-30 | $5.6M | 263k | 21.20 |
| 2021-03-31 | $3.1M | 153k | 20.29 |
| 2020-12-31 | $4.3M | 164k | 26.54 |